Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer.
- Published in:
- Journal of Neuro-Oncology, 2007, v. 85, n. 3, p. 311, doi. 10.1007/s11060-007-9420-5
- By:
- Publication type:
- Article
Works matching AU Altorjai, Gabriela
Results: 19
1
2
Long-Term Swallowing Outcome and Dysphagia in Advanced Staged Head and Neck Squamous Cell Carcinomas after Radiotherapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 10, p. 2688, doi. 10.3390/jcm11102688
- By:
- Publication type:
- Article
3
A survey on oral health‐related standard of care for head and neck cancer patients in the EU.
- Published in:
- Oral Diseases, 2024, v. 30, n. 4, p. 1935, doi. 10.1111/odi.14685
- By:
- Publication type:
- Article
4
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 903, doi. 10.1007/s00280-008-0682-1
- By:
- Publication type:
- Article
5
Effect of mannitol‐based reduced‐volume hydration on kidney function in concomitant cisplatin‐based chemoradiation for head‐and‐neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2023, v. 45, n. 8, p. 2087, doi. 10.1002/hed.27438
- By:
- Publication type:
- Article
6
Prognostic survival value of retropharyngeal lymph node involvement in sinonasal tumors: A retrospective, descriptive, and exploratory study.
- Published in:
- Head & Neck, 2017, v. 39, n. 7, p. 1421, doi. 10.1002/hed.24782
- By:
- Publication type:
- Article
7
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel  G-CSF.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 104, n. 1, p. 109, doi. 10.1007/s10549-006-9397-3
- By:
- Publication type:
- Article
8
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 102, n. 3, p. 375, doi. 10.1007/s10549-006-9342-5
- By:
- Publication type:
- Article
9
Post‐laryngectomy adjuvant radiotherapy in patients with pharyngocutaneous fistulae: Treatment regimens, outcomes and complications in 67 patients.
- Published in:
- Clinical Otolaryngology, 2019, v. 44, n. 5, p. 810, doi. 10.1111/coa.13353
- By:
- Publication type:
- Article
10
Dysregulation of ß‐catenin, WISP1 and TCF21 predicts disease‐specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck.
- Published in:
- Clinical Otolaryngology, 2019, v. 44, n. 3, p. 263, doi. 10.1111/coa.13281
- By:
- Publication type:
- Article
11
Accuracy of fine‐needle aspiration cytology in suspicious neck nodes after radiotherapy: Retrospective analysis of 100 patients.
- Published in:
- Clinical Otolaryngology, 2019, v. 44, n. 3, p. 384, doi. 10.1111/coa.13271
- By:
- Publication type:
- Article
12
Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy.
- Published in:
- Strahlentherapie und Onkologie, 2015, v. 191, n. 3, p. 209, doi. 10.1007/s00066-014-0753-7
- By:
- Publication type:
- Article
13
AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation.
- Published in:
- Acta Oto-Laryngologica, 2017, v. 137, n. 3, p. 320, doi. 10.1080/00016489.2016.1242776
- By:
- Publication type:
- Article
14
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
- Published in:
- BMC Cancer, 2006, v. 6, p. 81, doi. 10.1186/1471-2407-6-81
- By:
- Publication type:
- Article
15
Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study.
- Published in:
- BMC Cancer, 2006, v. 6, p. 63, doi. 10.1186/1471-2407-6-63
- By:
- Publication type:
- Article
16
Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
17
Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 21/22, p. 1117, doi. 10.1007/s00508-021-01885-0
- By:
- Publication type:
- Article
18
ART for head and neck patients: On the difference between VMAT and IMPT.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 8, p. 1166, doi. 10.3109/0284186X.2015.1028590
- By:
- Publication type:
- Article
19
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 7, doi. 10.1186/1472-6904-7-7
- By:
- Publication type:
- Article